Intellia Therapeutics, Inc. - NTLA

Sector: Healthcare · Industry: In Vitro & In Vivo Diagnostic Substances
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$994.9M
QoQ value delta ($000)
-$882.2M (-47.0%)
Implied price effect (QoQ)
-47.85%
Shares
Total shares
110,488,690
QoQ shares delta
+1,764,966 (+1.62%)
Total shares held by funds (by quarter)

Market chart (NTLA)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 32 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
ARK Investment Management LLC 127,723 14,207,324 0.85%
VANGUARD GROUP INC 116,959 13,010,001 0.0%
BlackRock, Inc. 92,388 10,276,849 0.0%
STATE STREET CORP 57,705 6,418,836 0.0%
D. E. Shaw & Co., Inc. 48,673 5,414,164 0.03%
REGENERON PHARMACEUTICALS, INC. 33,289 3,702,995 98.49%
TWO SIGMA INVESTMENTS, LP 24,261 2,698,738 0.03%
GEODE CAPITAL MANAGEMENT, LLC 24,242 2,696,187 0.0%
TWO SIGMA ADVISERS, LP 21,093 2,346,317 0.04%
MORGAN STANLEY 20,927 2,327,852 0.0%
Sumitomo Mitsui Trust Group, Inc. 19,710 2,192,461 0.01%
Amova Asset Management Americas, Inc. 19,688 2,192,461 0.23%
CITADEL ADVISORS LLC 19,220 2,137,950 0.0%
DIMENSIONAL FUND ADVISORS LP 17,367 1,931,849 0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 16,976 1,888,365 0.0%
FMR LLC 15,821 1,759,898 0.0%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 15,619 1,737,450 0.05%
RENAISSANCE TECHNOLOGIES LLC 15,037 1,672,700 0.02%
GOLDMAN SACHS GROUP INC 13,086 1,455,619 0.0%
BANK OF AMERICA CORP /DE/ 11,168 1,242,378 0.0%
UBS Group AG 11,127 1,237,736 0.0%
ARMISTICE CAPITAL, LLC 10,392 1,156,000 0.12%
JUPITER ASSET MANAGEMENT LTD 9,330 1,037,918 0.07%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 8,502 945,756 0.0%
STIFEL FINANCIAL CORP 8,373 931,391 0.01%